Open AccessPostpartum extracorporeal membrane oxygenation of a woman with COVID-19-related acute respiratory distress syndrome
Author(s) -
Wei Huang,
Cheng Zhou,
Xinxue Liao,
Liqiang Wang,
Junlin Wen,
Jianwei Li,
Haiming Jiang,
Yuan Yao,
Binfei Li
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026798
Subject(s) - medicine , ards , extracorporeal membrane oxygenation , anesthesia , mechanical ventilation , intensive care medicine , lung
Patients with coronavirus disease (COVID-19) may develop acute respiratory distress syndrome (ARDS). There have been few reports of postpartum woman with ARDS secondary to COVID-19 who required respiratory support using veno-venous extracorporeal membrane oxygenation (ECMO). We present the case of a 31-year-old woman who was admitted to hospital at 35 weeks gestation with ARDS secondary to COVID-19 and required ECMO during the postpartum period. Patient concerns: The patient had obvious dyspnea, accompanied by chills and fever. Her dyspnea worsened and her arterial oxygen saturation decreased rapidly. Diagnosis: ARDS secondary to COVID-19. Interventions: Emergency bedside cesarean section. Medications included immunotherapy (thymosin α 1), antivirals (lopinavir/ritonavir and ribavirin), antibiotics (imipenem-cilastatin sodium and vancomycin), and methylprednisolone. Ventilatory support was provided using invasive mechanical ventilation. This was replaced by venous-venous ECMO 5 days postpartum. ECMO management focused on blood volume control, coagulation function adjustment, and airway management. Outcomes: The patient was successfully weaned for ECMO and the ventilator and made a good recovery. Conclusion: Special care, including blood volume control, coagulation function adjustment, and airway management, should be provided to postpartum patients with ARDS secondary to COVID-19 who require ECMO support.